§ 54.1-3435.1. Denial, revocation, and suspension of license as wholesaledistributor or of registration as a nonresident wholesale distributor.
A. The Board may deny, revoke, suspend, or take other disciplinary actionsagainst a wholesale distributor license or nonresident wholesale distributorregistration as provided for in § 54.1-3316 or the following:
1. Any conviction of the applicant, licensee, or registrant under federal orstate laws relating to controlled substances, including, but not limited to,drug samples and wholesale or retail prescription drug distribution;
2. Violations of licensing requirements under previously held licenses;
3. Failure to maintain and make available to the Board or to federalregulatory officials those records required to be maintained by wholesaledistributors of prescription drugs; or
4. Violations of the minimum requirements for qualifications, personnel,storage, and handling of prescription drugs and maintenance of prescriptiondrug records as set forth in the federal Prescription Drug Marketing Act of1987 (21 U.S.C. §§ 333, 353 and 381) and Part 205 of Chapter 21 of the Codeof Federal Regulations.
B. Wholesale drug distributors shall allow the Board or its authorized agentsto enter and inspect, at reasonable times and in a reasonable manner, theirpremises and delivery vehicles, and to audit their records and writtenoperating procedures. Such agents shall be required to show appropriateidentification prior to being permitted access to wholesale drugdistributors' premises and delivery vehicles.
§ 54.1-3435.1. Denial, revocation, and suspension of license as wholesaledistributor or of registration as a nonresident wholesale distributor.
A. The Board may deny, revoke, suspend, or take other disciplinary actionsagainst a wholesale distributor license or nonresident wholesale distributorregistration as provided for in § 54.1-3316 or the following:
1. Any conviction of the applicant, licensee, or registrant under federal orstate laws relating to controlled substances, including, but not limited to,drug samples and wholesale or retail prescription drug distribution;
2. Violations of licensing requirements under previously held licenses;
3. Failure to maintain and make available to the Board or to federalregulatory officials those records required to be maintained by wholesaledistributors of prescription drugs; or
4. Violations of the minimum requirements for qualifications, personnel,storage, and handling of prescription drugs and maintenance of prescriptiondrug records as set forth in the federal Prescription Drug Marketing Act of1987 (21 U.S.C. §§ 333, 353 and 381) and Part 205 of Chapter 21 of the Codeof Federal Regulations.
B. Wholesale drug distributors shall allow the Board or its authorized agentsto enter and inspect, at reasonable times and in a reasonable manner, theirpremises and delivery vehicles, and to audit their records and writtenoperating procedures. Such agents shall be required to show appropriateidentification prior to being permitted access to wholesale drugdistributors' premises and delivery vehicles.
§ 54.1-3435.1. Denial, revocation, and suspension of license as wholesaledistributor or of registration as a nonresident wholesale distributor.
A. The Board may deny, revoke, suspend, or take other disciplinary actionsagainst a wholesale distributor license or nonresident wholesale distributorregistration as provided for in § 54.1-3316 or the following:
1. Any conviction of the applicant, licensee, or registrant under federal orstate laws relating to controlled substances, including, but not limited to,drug samples and wholesale or retail prescription drug distribution;
2. Violations of licensing requirements under previously held licenses;
3. Failure to maintain and make available to the Board or to federalregulatory officials those records required to be maintained by wholesaledistributors of prescription drugs; or
4. Violations of the minimum requirements for qualifications, personnel,storage, and handling of prescription drugs and maintenance of prescriptiondrug records as set forth in the federal Prescription Drug Marketing Act of1987 (21 U.S.C. §§ 333, 353 and 381) and Part 205 of Chapter 21 of the Codeof Federal Regulations.
B. Wholesale drug distributors shall allow the Board or its authorized agentsto enter and inspect, at reasonable times and in a reasonable manner, theirpremises and delivery vehicles, and to audit their records and writtenoperating procedures. Such agents shall be required to show appropriateidentification prior to being permitted access to wholesale drugdistributors' premises and delivery vehicles.
